International Patent: LONG-ACTING INJECTABLE FORMULATIONS OF HIV REVERSE TRANSCRIPTASE INHIBITORS

GENEVA, Sept. 18 -- MERCK SHARP & DOHME LLC filed a patent application (US2026/018005) for “LONG-ACTING INJECTABLE FORMULATIONS OF HIV REVERSE TRANSCRIPTASE INHIBITORS”. With publication no. WO/2026/188095, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/13

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....